Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$36.74 - $81.08 $105,590 - $233,023
2,874 New
2,874 $226,000
Q4 2019

Feb 14, 2020

SELL
$16.61 - $21.64 $158,990 - $207,138
-9,572 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$20.27 - $28.93 $35,472 - $50,627
1,750 Added 22.37%
9,572 $227,000
Q2 2019

Aug 14, 2019

BUY
$22.36 - $30.41 $174,899 - $237,867
7,822 New
7,822 $227,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.18B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.